Eledon Pharmaceuticals Inc (ELDN)
EBITDA Growth
-25.78%
Quarterly · Period ending:
ELDN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-25.78%period ending
Latest reported-25.78%period ending
ELDN Quarterly EBITDA YoY % (-90.98% → -25.78%)
Year-over-year change
High-resolution chart · PNG
ELDN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -25.7846% | |
| -500.8468% | |
| 76.5726% | |
| -122.6593% | |
| 74.9699% | |
| 72.404% | |
| -379.6389% | |
| 885.2629% | |
| 31.7607% | |
| -120.3745% | |
| 7.5701% | |
| 5.4538% | |
| -617.426% | |
| -9.359% | |
| -6.6817% | |
| 0.7745% | |
| -15.4516% | |
| -9.0077% | |
| -47.6952% | |
| -143.2326% | |
| -285.7908% | |
| -168.8776% | |
| -180.0799% | |
| -49.6173% | |
| 49.184% | |
| 31.0145% | |
| 50.7215% | |
| 17.7918% | |
| -26.8905% | |
| -72.9943% | |
| -117.7059% | |
| -17.9885% | |
| 52.104% | |
| -102.1723% | |
| 43.8686% | |
| -88.9668% | |
| -656.1364% | |
| 87.9146% | |
| 66.0221% | |
| 86.7958% | |
| 90.1851% | |
| 14.0504% | |
| -76.087% | |
| -84.9977% | |
| -52.5349% | |
| -171.9926% | |
| -13.2923% | |
| -90.9848% |